Moneycontrol
Get App
Close Ad
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Arvind Remedies

BSE: 531823|NSE: ARVINDREM|ISIN: INE211C01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
Arvind Remedies is not traded in the last 30 days
Arvind Remedies is not traded in the last 30 days
Announcements on Arvind Remedies

17th-Aug-2016 13:13Source: NSE

Arvind Remedies Limited

Arvind Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 12, 2016, decided to defer all other items, intimated vide Company's letter d...

13th-Aug-2016 14:23Source: BSE

Arvind Remedies- Limited Review Report for June 30, 2016

Arvind Remedies Ltd has informed BSE about : 1. Standalone Limited Review for the period ended June 30, 2016

12th-Aug-2016 19:30Source: BSE

Arvind Remedies- Outcome of Board Meeting

Arvind Remedies Ltd has informed BSE about Outcome of Board Meeting held on August 12, 2016.

12th-Aug-2016 19:25Source: BSE

Arvind Remedies- Standalone Financial Results for June 30, 2016

Arvind Remedies Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 2016

2nd-Aug-2016 22:02Source: BSE

Arvind Remedies- Board Meeting on August 12, 2016

Arvind Remedies Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 12, 2016

25th-Jul-2016 13:47Source: BSE

Arvind Remedies- Shareholding for the Period Ended June 30, 2016

Arvind Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here

25th-Jul-2016 13:46Source: BSE

Arvind Remedies- Shareholding for the Period Ended March 31, 2016

Arvind Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here

1st-Jun-2016 17:07Source: BSE

Arvind Remedies- Statement on Impact of Audit Qualifications for the period ended March 31, 2016

Arvind Remedies Ltd has submitted to BSE a copy of Standalone Statement on Impact of Audit Qualifications for the period ended March 31, 2016.

31st-May-2016 11:16Source: BSE

Arvind Remedies- Standalone Financial Results, Auditors Report for March 31, 2016

Arvind Remedies Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 20162. Standalone Auditors Report for the period ended March 31, 2016

24th-May-2016 13:14Source: BSE

Arvind Remedies- Board Meeting Intimation for Results & Closure of Trading Window

Arvind Remedies Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on May 30, 2016, inter alia, to consider the following item:- To consider the aud...

1 2 3 4 5 Next >>
Quick Links for Arvind Remedies
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.